XMEX
FRAGUAB
Market cap2.43bUSD
Sep 17, Last price
435.00MXN
1D
-0.46%
1Q
-2.77%
Jan 2017
62.93%
Name
Corporativo Fragua SAB de CV
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Corporativo Fragua, S.A.B. de C.V. is a holding company that operates a chain of pharmacy stores in Mexico under the Farmacias Guadalajara brand. The company is engaged in the retail of medicines, perfumes, photography equipment, household goods, food, and other miscellaneous items. It also provides various services including maintenance, surveillance, medical services, and logistics.
Key people
Javier Arroyo Chavez
Chairman of the Board and Chief Executive Officer · since 2004
Guillermina Arroyo Chavez
Vice Chairman of the Board, Director of Personal Development · since 2003
Maria Fernanda Garcia Orozco
Chief Financial Officer · since 2016
Irene Belloso Villalvazo
Chief Accounting Officer
Julieta Mora Chavez
Chief Marketing Officer, Advertising
Griselda Reynaga Balbaneda
Chief Marketing Officer, Promotions
Enrique Lara Valdez
General Manager of Photosystems
Jose Antonio Jimenez Garcia
Sub-Treasurer · since 2015
Javier Arroyo Navarro
Deputy General Director · since 2016
Hector H. Rodriguez Bautista
Director of Sale Point
Margarita Paloma Farias Gonzalez
Director of Human Resources · since 2016
Francisco Arroyo Jimenez
Director of Operation Managers Coordination, Director
Rosa Maria Becerra Aguilar
Director of Payment to Suppliers
Lluvia Guadalupe Fierro Salas
Director of Development · since 2015
Jaime Garay Nuno
Corporate Attorney · since 2016
Emanuel Garcia Bayardo
Manager of Cedis Noreste
Julio Garcia Gonzalez
Director of Northeast Cedis
Rodrigo Gonzalez Reynoso
Director of Internal Audit
Jose Ibarra Lara
Director of Systems
Carlos Ordonez Pindter
Director of Purchase
IPO date
Oct 03, 1997
Employees
Domiciled in
MX
Incorporated in
MX
Valuation
Title MXN in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||